The U.S. Food and Drug Administration on Wednesday approved the first fecal microbiota treatment, aimed at helping adults battling tough-to-treat Clostridium difficile (C. diff) infections.
Dec 1, 2022
0
4
For patients with treatment-resistant depression (TRD), minocycline as add-on to antidepressant treatment as usual does not reduce depressive symptoms, according to a study published online Sept. 14 in JAMA Network Open.
Sep 15, 2022
0
6
For boys with Duchenne muscular dystrophy (DMD), vamorolone, a structurally unique dissociative steroidal anti-inflammatory drug, is effective and safe over a 24-week period, according to a study published online Aug. 29 ...
Sep 1, 2022
0
3
Placebos are fake treatments that are crucial in clinical trials to test if a treatment actually works or whether benefits are merely due to receiving an apparently credible treatment from a trusted clinician. But placebos ...
Aug 4, 2022
0
6
For individuals with opioid use disorder undergoing a buprenorphine/naloxone taper, suvorexant might be a promising treatment for reducing sleep disturbance and easing opioid withdrawal, according to a study published online ...
Jul 12, 2022
0
30
Pregnancy chances in IVF can be affected by many factors including the type of bacteria which naturally colonize the reproductive tract. 'Good' bacteria in the form of probiotics are of increasing interest in treating women ...
Jul 4, 2022
0
4
The Food and Drug Administration on Monday approved a drug called baricitinib as the first oral tablet for treating severe alopecia areata, an autoimmune disorder affecting more than 300,000 people in the United States every ...
Jun 14, 2022
0
8
A greater proportion of patients with severe, uncontrolled asthma had more significant clinical responses to tezepelumab than placebo, according to research published at the ATS 2022 international conference. The study showed ...
May 17, 2022
0
11
Hydrocortisone is no more effective than placebo at preventing damage that can result from oxygen and ventilator therapy necessary to keep preterm infants alive, according to research funded by the National Institutes of ...
Mar 24, 2022
0
6
For nonhospitalized patients with symptomatic mild-to-moderate COVID-19 and a high risk for progression, risk for all-cause hospitalization or death is reduced with sotrovimab versus placebo, according to a study published ...
Mar 18, 2022
0
12
